Form preview

Get the free 510(k) Summary for eSensor® Warfarin Sensitivity Test and XT-8 System - accessdata fda

Get Form
This document provides a summary of the 510(k) safety and effectiveness information regarding the eSensor® Warfarin Sensitivity Test and XT-8 System. It includes device descriptions, intended uses,
We are not affiliated with any brand or entity on this form

Get, Create, Make and Sign 510k summary for esensor

Edit
Edit your 510k summary for esensor form online
Type text, complete fillable fields, insert images, highlight or blackout data for discretion, add comments, and more.
Add
Add your legally-binding signature
Draw or type your signature, upload a signature image, or capture it with your digital camera.
Share
Share your form instantly
Email, fax, or share your 510k summary for esensor form via URL. You can also download, print, or export forms to your preferred cloud storage service.

Editing 510k summary for esensor online

9.5
Ease of Setup
pdfFiller User Ratings on G2
9.0
Ease of Use
pdfFiller User Ratings on G2
In order to make advantage of the professional PDF editor, follow these steps:
1
Log in to account. Start Free Trial and sign up a profile if you don't have one.
2
Prepare a file. Use the Add New button. Then upload your file to the system from your device, importing it from internal mail, the cloud, or by adding its URL.
3
Edit 510k summary for esensor. Text may be added and replaced, new objects can be included, pages can be rearranged, watermarks and page numbers can be added, and so on. When you're done editing, click Done and then go to the Documents tab to combine, divide, lock, or unlock the file.
4
Save your file. Select it from your records list. Then, click the right toolbar and select one of the various exporting options: save in numerous formats, download as PDF, email, or cloud.
With pdfFiller, it's always easy to work with documents.

Uncompromising security for your PDF editing and eSignature needs

Your private information is safe with pdfFiller. We employ end-to-end encryption, secure cloud storage, and advanced access control to protect your documents and maintain regulatory compliance.
GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

How to fill out 510k summary for esensor

Illustration

How to fill out 510(k) Summary for eSensor® Warfarin Sensitivity Test and XT-8 System

01
Gather all necessary information about the eSensor® Warfarin Sensitivity Test and XT-8 System.
02
Include a description of the device, its intended use, and the patients it serves.
03
Detail the technological characteristics of the device and any materials used.
04
Provide information on performance testing, including any clinical studies or data supporting the device's efficacy.
05
Compare the device to a legally marketed predicate device to establish substantial equivalence.
06
Include labeling information, including instructions for use and any promotional materials.
07
Submit the completed 510(k) Summary to the FDA, ensuring all formatting and documentation guidelines are followed.

Who needs 510(k) Summary for eSensor® Warfarin Sensitivity Test and XT-8 System?

01
Manufacturers of the eSensor® Warfarin Sensitivity Test and XT-8 System must prepare the 510(k) Summary.
02
Healthcare professionals and organizations aiming to use or distribute the device require the 510(k) Summary for regulatory compliance.
03
Regulatory agencies need the 510(k) Summary to evaluate and approve the device for safe market entry.
Fill form : Try Risk Free
Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Easiest To Do Business With - Summer 2025
Best Meets Requirements- Summer 2025
Rate the form
4.8
Satisfied
47 Votes

People Also Ask about

If people with warfarin sensitivity take the average dose (or more) of warfarin, they are at risk of an overdose, which can cause abnormal bleeding in the brain, gastrointestinal tract, or other tissues, and may lead to serious health problems or death.
Symptoms of overdose may include the following: bloody or red, or tarry movements. spitting or coughing up blood. heavy bleeding with your menstrual period. pink, red, or dark brown . coughing up or vomiting material that looks like coffee grounds. small, flat, round red spots under the skin.
If bleeding risk is high* or INR >4.5, consider Vitamin K1 1–2 mg orally or 0.5–1 mg IV. Lower or omit the next dose of warfarin. Resume therapy at a lower warfarin dose when the INR approaches therapeutic range. Cease warfarin therapy; consider reasons for elevated INR and patient-specific factors.
Warfarin sensitivity testing will identify the CYP2C9 and VKORC1 genetic variants (i.e., genotype) present for the person tested. The results must be interpreted carefully to help determine if the person is likely to need a relatively lower or higher dose of warfarin. These results are interpreted by a specialist.
Talk to your healthcare team if you take warfarin and have these symptoms: Bleeding from a cut or the nose or gums that lasts less than 5 minutes. For example, if your gums bleed after brushing your teeth. Bleeding between menstrual periods. Diarrhea, vomiting or inability to eat for more than 24 hours. Fever.
Anticoagulant therapies such as heparin and warfarin are considered high-alert medications, due to the high potential for patient harm if used improperly.
Warfarin sensitivity testing will identify the CYP2C9 and VKORC1 genetic variants (i.e., genotype) present for the person tested. The results must be interpreted carefully to help determine if the person is likely to need a relatively lower or higher dose of warfarin. These results are interpreted by a specialist.

For pdfFiller’s FAQs

Below is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

The 510(k) Summary for the eSensor® Warfarin Sensitivity Test and XT-8 System is a premarket submission made to the FDA demonstrating that the device is safe and effective, and substantially equivalent to a legally marketed device.
Manufacturers or developers of the eSensor® Warfarin Sensitivity Test and XT-8 System are required to file a 510(k) Summary with the FDA.
To fill out the 510(k) Summary, the manufacturer must provide detailed information about the device, including its intended use, description, technological characteristics, performance data, labeling, and any substantial equivalence claims.
The purpose of the 510(k) Summary is to demonstrate to the FDA that the eSensor® Warfarin Sensitivity Test and XT-8 System is safe and effective for its intended use and to establish its equivalence to existing marketed devices.
The information that must be reported includes device name, intended use, description of the technology, comparison to predicate devices, labeling information, and any clinical or non-clinical data supporting the device's safety and effectiveness.
Fill out your 510k summary for esensor online with pdfFiller!

pdfFiller is an end-to-end solution for managing, creating, and editing documents and forms in the cloud. Save time and hassle by preparing your tax forms online.

Get started now
Form preview
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.